Advanced search
Publication Cover
Journal of Enzyme Inhibition and Medicinal Chemistry Volume 37, 2022 - Issue 1
Submit an article Journal homepage
2,513
Views
15
CrossRef citations to date
0
Altmetric
Research Papers

Structure-activity relationship studies for inhibitors for vancomycin-resistant Enterococcus and human carbonic anhydrases

Weiwei Ana Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USAView further author information
,
Katrina J. Hollya Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USAORCID Iconhttps://orcid.org/0000-0002-5193-4503View further author information
ORCID Icon,
Alessio Nocentinib Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, ItalyORCID Iconhttps://orcid.org/0000-0003-3342-702XView further author information
ORCID Icon,
Ryan D. Imhoffa Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USAORCID Iconhttps://orcid.org/0000-0002-8510-8437View further author information
ORCID Icon,
Chad. S. Hewitta Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USAView further author information
,
Nader S. Abutalebc Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USA;d Center for Emerging, Zoonotic and Arthropod-Borne Pathogens, Virginia Polytechnic Institute and State University, Blacksburg, VA, USAView further author information
,
Xufeng Caoa Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USAView further author information
,
Mohamed N. Seleemb Department of NEUROFARBA, Section of Pharmaceutical and Nutraceutical Sciences, University of Florence, Firenze, Italy;d Center for Emerging, Zoonotic and Arthropod-Borne Pathogens, Virginia Polytechnic Institute and State University, Blacksburg, VA, USAORCID Iconhttps://orcid.org/0000-0003-0939-0458View further author information
ORCID Icon,
Claudiu T. Supuranc Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-4262-0323View further author information
ORCID Icon &
Daniel P. Flahertya Department of Medicinal Chemistry and Molecular Pharmacology, College of Pharmacy, Purdue University, West Lafayette, IN, USA;e Purdue Institute for Drug Discovery, West Lafayette, IN, USA;f Purdue Institute of Inflammation, Immunology and Infectious Disease, West Lafayette, IN, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-8305-0606View further author information
ORCID Icon show all
Pages 1838-1844 | Received 25 May 2022, Accepted 16 Jun 2022, Published online: 27 Jun 2022

References

  • Boucher HW, Talbot GH, Bradley JS, et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dise 2009;48:1–12.
  • Antibiotic resistance threats in the United States, Centers for Disease Control and Prevention 2019; Atlanta, Georgia; 2019.
  • Sherman JM. The Streptococci. Bacteriol Rev 1937;1:3–97.
  • MacCallum WG, Hastings TW. A case of acute endocarditis caused by Micrococcus zymogenes (Nov. Spec.), with a description of the microorganism. J Exp Med 1899; 4:521–34.
  • Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol 2012;10:266–78.
  • Murray BE. The life and times of the Enterococcus. Clinical Microbiol Rev 1990;3:46–65.
  • Sievert DM, Ricks P, Edwards JR, National Healthcare Safety Network (NHSN) Team and Participating NHSN Facilities, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009–2010. Infect Cont Hosp Epidemiol 2013;34:1–14.
  • Britt NS, Potter EM, Patel N, Steed ME. Effect of continuous and sequential therapy among veterans receiving daptomycin or linezolid for vancomycin-resistant Enterococcus Faecium bacteremia. Antimicrob Agent Chemother 2017;61:e02216–16.
  • Dhanda G, Sarkar P, Samaddar S, Haldar J. Battle against vancomycin-resistant bacteria: recent developments in chemical strategies. J Med Chem 2019;62:3184–205.
  • Younis W, AbdelKhalek A, Mayhoub AS, Seleem MN. In vitro screening of an FDA-approved library against ESKAPE pathogens. Curr Pharm Des 2017;23:2147–2157.
  • Kaur J, Cao X, Abutaleb NS, et al. Optimization of acetazolamide-based scaffold as potent inhibitors of vancomycin-resistant Enterococcus. J Med Chem 2020;63:9540–62.
  • Supuran CT. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 2008;7:168–81.
  • del Prete S, Nocentini A, Supuran CT, Capasso C. Bacterial ι-carbonic anhydrase: a new active class of carbonic anhydrase identified in the genome of the gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2020;35:1060–8.
  • Smith KS, Ferry JG. Prokaryotic carbonic anhydrases. FEMS Microbiol Rev 2000;24:335–66.
  • Supuran CT. Structure and function of carbonic anhydrases. Biochem J 2016;473:2023–32.
  • Modak JK, Liu YC, Supuran CT, Roujeinikova A. Structure-activity relationship for sulfonamide inhibition of Helicobacter pylori α-carbonic anhydrase. J Med Chem 2016;59:11098–109.
  • Nishimori I, Minakuchi T, Morimoto K, et al. Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the α-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs. J Med Chem 2006;49:2117–26.
  • Remmele CW, Xian Y, Albrecht M, et al. Transcriptional landscape and essential genes of Neisseria gonorrhoeae. Nucleic Acids Res 2014;42:10579–95.
  • Hewitt CS, Abutaleb NS, Elhassanny AEM, et al. Structure-activity relationship studies of acetazolamide-based carbonic anhydrase inhibitors with activity against Neisseria gonorrhoeae. ACS Infect Dis 2021;7:1969–84.
  • Petreni A, De Luca V, Scaloni A, et al. Anion inhibition studies of the Zn(II)-bound ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhibit Med Chem 2021;36:372–6.
  • Vullo D, Del Prete S, Osman SM, et al. Sulfonamide inhibition studies of the γ-carbonic anhydrase from the oral pathogen Porphyromonas gingivalis. Bioorg Med Chem Lett 2014;24:240–4.
  • Turkmen H, Durgun M, Yilmaztekin S, et al. Carbonic anhydrase inhibitors. novel sulfanilamide/acetazolamide derivatives obtained by the tail approach and their interaction with the cytosolic isozymes I and II, and the tumor-associated isozyme IX. Bioorg Med Chem Lett 2005;15:367–72.
  • Di Cesare Mannelli L, Micheli L, Carta F, et al. Carbonic anhydrase inhibition for the management of cerebral ischemia: in vivo evaluation of sulfonamide and coumarin inhibitors. J Enzyme Inhibit Med Chem 2016;31:894–9.
  • Nocentini A, Hewitt CS, Mastrolorenzo MD, et al. Anion inhibition studies of the α-carbonic anhydrases from Neisseria gonorrhoeae. J Enzyme Inhibit Med Chem 2021;36:1061–6.
  • Yung-Chi C, Prusoff WH. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973;22:3099–108.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.